United States
Print page content Print
Increase text size Decrease text size
Text Size

CLAVAMOX® (AMOXICILLIN / CLAVULANIC ACID)

Unique dual mode of action provides broad spectrum coverage

CLAVAMOX is the only potentiated penicillin approved for veterinary use in dogs and cats. CLAVAMOX combines the broad-spectrum antibiotic activity of amoxicillin with unique β-lactamase-inhibiting effect of clavulanic acid for powerful, broad-spectrum antimicrobial activity.

In dogs:

  • Skin and soft tissue infections such as wounds, abscesses, cellulitis, superficial/juvenile and deep pyoderma due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., and Escherchia coli.
  • Periodontal infections due to susceptible strains of both aerobic and anaerobic bacteria.


In cats:

  • Skin and soft tissue infections such as wounds, abscesses, cellulitis/dermatitis due to susceptible strains of the following organisms: β-lactamase-producing Staphylococcus aureus, non-β-lactamase-producing Staphylococcus aureus, Staphylococcus spp., Streptococcus spp., Escherchia coli and Pasteurella spp.
  • Urinary tract infections (cystitis) due to susceptible strains of Escherchia coli.
Expand All
    • Combines broad-spectrum antibiotic activity of amoxicillin with unique β-lactamase-inhibiting effect of clavulanic acid, which extends the antibacterial spectrum to include β-lactamase-producing organisms.
    • Has activity against many Gram-positive and Gram-negative aerobic and anaerobic bacteria.
    • Effective in treating skin infections in dogs and cats, periodontal infections in dogs, and urinary tract infections in cats.
    • Over 25 years of proven experience and successful outcomes.


Important Safety Information
People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to CLAVAMOX. Do not use in animals with a history of allergic reactions to penicillins or cephalosporins.

For more safety information, please refer to the full Prescribing Information.